Phase 1 Safety and Pharmacokinetic Study of AI-700 in Patients With Diminished DLCO and COPD and/or CHF
NCT00156780 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2006-10-23
Summary
This study was conducted to evaluate the safety and pharmacokinetics of an echocardiographic contrast agent, AI-700, in patients with moderate to severe chronic obstructive pulmonary disease (COPD) and/or congestive heart failure (CHF).
Conditions
- Congestive Heart Failure
- Chronic Obstructive Pulmonary Disease
Interventions
- DRUG
-
AI-700
Sponsors & Collaborators
-
Acusphere
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- ECT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Sex
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-08-31
- Completion
- 2005-07-31
Countries
- United States
Study Locations
More Related Trials
-
Study of JK07 in Patients With Chronic Heart Failure
NCT06369298 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study to Assess the Safety, Tolerability and PK/PD After 4 Weekly SC Injections of PB1046 in Subjects With Stable HFrEF
NCT02808585 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Preserved Ejection Fraction
NCT03098979 ·Status: COMPLETED ·Phase: PHASE2
-
Study of HS135 in Obese Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction
NCT06581159 ·Status: TERMINATED ·Phase: PHASE1
-
Pilot Feasibility Study of the Safety and Efficacy of Anakinra in Heart Failure With Preserved Ejection Fraction
NCT01542502 ·Status: COMPLETED ·Phase: NA
-
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation
NCT05636176 ·Status: RECRUITING ·Phase: PHASE3
-
Study to Assess the Safety of BAY1067197 in Stable Heart Failure Patients on Standard Therapy Including ß-blocker
NCT01945606 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of CRD-740 in Heart Failure
NCT05409183 ·Status: TERMINATED ·Phase: PHASE2
-
A Phase IIb Study to Investigate the Efficacy and Tolerability of Lower Doses Cinaciguat (25 µg/h, 10 µg/h) Given Intravenously to Patients With Acute Decompensated Chronic Congestive Heart Failure (ADHF)
NCT01067859 ·Status: TERMINATED ·Phase: PHASE2
-
The Effects of IL-1 Blockade on Inotrope Sensitivity in Patients With Heart Failure (AID-HEART)
NCT06062966 ·Status: RECRUITING ·Phase: PHASE1
-
Multiple Dose Study in Heart Failure of BAY 1067197
NCT02040233 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of Safety, Tolerability, Immunogenicity, and Pharmacokinetics of AZD3427
NCT04630067 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of an Intravenous Solution of JNJ-39588146 or Placebo in Patients With Heart Failure
NCT01120210 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase IIb Study to Investigate the Efficacy and Tolerability of Cinaciguat (150 µg/h, 100 µg/h, 50 µg/h) Given Intravenously to Subjects With Acute Decompensated Chronic Congestive Heart Failure (ADHF)
NCT01064037 ·Status: TERMINATED ·Phase: PHASE2
-
Study in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
NCT06560762 ·Status: RECRUITING ·Phase: PHASE1
-
A Phase IIb Study of AZD5462 in Patients With Chronic Heart Failure
NCT06299826 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Reduced Ejection Fraction (Cycle-1-REF)
NCT06215911 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of TRC041266 in Patients With Heart Failure, LVEF ≥40%, Diastolic Dysfunction and Type 2 Diabetes Mellitus
NCT04507347 ·Status: WITHDRAWN ·Phase: PHASE3
-
Phase II Clinical Study of HRS-9057 Injection in Patients With Heart Failure-induced Fluid Retention
NCT07318103 ·Status: RECRUITING ·Phase: PHASE2
-
Single-Ascending Dose Study of JK07 in Subjects With HFpEF
NCT05322616 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Study of CLR325 in Chronic Stable Heart Failure Patients.
NCT02696967 ·Status: COMPLETED ·Phase: PHASE2
-
Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Preserved Ejection Fraction (Cycle-2-PEF)
NCT06215586 ·Status: COMPLETED ·Phase: PHASE2
-
Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension
NCT07221513 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
NCT01357850 ·Status: COMPLETED ·Phase: PHASE2
-
Study of HS235 in Obese Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction (HFpEF)
NCT07123779 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1